Impact of Herbal Medicines like Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida, on Cytochrome P450 2C11 Gene Expression in Rat Liver

Abstract

Aim: Combined use of herbs and drugs may result in clinically important herb-drug interactions. The majorities of these interactions are thought to be metabolism-based and involve induction or inhibition of cytochrome P450 (CYP). The current study was designed to investigate the effect of some commonly used herbs on rat CYP2C11 gene expression and metabolic activity.

Methods: Wistar rats were treated for 7 days with increasing doses of 3 herbs; Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida. Thereafter, CYP2C11 mRNA and protein levels were determined by real-time polymerase chain reaction (RT-PCR) and western blot analyses, respectively. In vitro metabolic activity of CYP2C11 was performed on rat hepatic microsomes using tolbutamide as specific substrate.

Results: Our results showed that all the 3 herbs significantly inhibited the mRNA and protein expression levels of CYP2C11 in a dose-dependent manner. Furthermore, the in vitro enzyme metabolic activity study showed a significant decrease in the formation of 4-hyroxy-tolbutamide, a tolbutamide metabolite, at the higher doses. The inhibitory effects of the investigated herbs on rat CYP2C11 was in the order: Nigella Sativa > Trigonella foenum-graecum > Ferula asafoetida.

Conclusions: The 3 herbs are strong inhibitor of CYP2C11 expression, which can lead to an undesirable pharmacological effect of clinically used CYP2C11 substrate drugs with a low therapeutic index.

Key words

CYP2C - gene expression - herb-drug interaction - rat microsomes

• References

• 1 Bayrak O, Bavbek N, Karatas OF et al. Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol Dial Transplant 2008; 23: 2206-2212
• 2 Ibrahim ZS, Ishizuka M, Soliman M et al. Protection by Nigella sativa against carbon tetrachloride-induced downregulation of hepatic cytochrome P450 isozymes in rats. Jpn J Vet Res 2008; 56: 119-128
• 3 Gurley BJ, Gardner SF, Hubbard MA et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002; 72: 276-287
• 4 Huang SM, Lesko LJ. Drug-drug drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?. J Clin Pharmacol 2004; 44: 559-569
• 5 Rettie AE, Jones JP. Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics. Annu Rev Pharmacol Toxicol 2005; 45: 477-494
• 6 Yeung JH, Chan SL, Or PM. Polysaccharide peptides from COV-1 strain of Coriolus versicolor inhibit tolbutamide 4-hydroxylation in the rat in vitro and in vivo. Food Chem Toxicol 2006; 44: 1414-1423
• 7 Brazier NC, Levine MA. Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am J Ther 2003; 10: 163-169
• 8 Markowitz JS, DeVane CL. The emerging recognition of herb-drug interactions with a focus on St. John’s wort (Hypericum perforatum). Psychopharmacol Bull 2001; 35: 53-64
• 9 Williamson EM. Drug interactions between herbal and prescription medicines. Drug Saf 2003; 26: 1075-1092
• 10 Diamond BJ, Shiflett SC, Feiwel N et al. Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 2000; 81: 668-678
• 11 Appiah-Opong R, Commandeur JN, Axson C et al. Interactions between cytochromes P450, glutathione S-transferases and Ghanaian medicinal plants. Food Chem Toxicol 2008; 46: 3598-3603
• 12 Galluzzi S, Zanetti O, Binetti G et al. Coma in a patient with Alzheimer’s disease taking low dose trazodone and gingko biloba. J Neurol Neurosurg Psychiatry 2000; 68: 679-680
• 13 EL-Dakhakhny M. Studies on the chemical constituents of Egyptian Nigella sativa L. seeds. The essential oil. Planta Med Planta Med 1963; 11: 465-470
• 14 Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003; 17: 299-305
• 15 Basch E, Ulbricht C, Kuo G et al. Therapeutic applications of fenugreek. Altern Med Rev 2003; 8: 20-27
• 16 Sowmya P, Rajyalakshmi P. Hypocholesterolemic effect of germinated fenugreek seeds in human subjects. Plant Foods Hum Nutr 1999; 53: 359-365
• 17 Balandrin MF, Klocke JA, Wurtele ES et al. Natural plant chemicals: sources of industrial and medicinal materials. Science 1985; 228: 1154-1160
• 18 Mahendra P, Bisht S. Ferula asafoetida: Traditional uses and pharmacological activity. Pharmacogn Rev 2012; 6: 141-146
• 19 Gupta A, Gupta R, Lal B. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study. J Assoc Physicians India 2001; 49: 1057-1061
• 20 Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N et al. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arh 2012; 66: 198-200
• 21 Qidwai W, Hamza HB, Qureshi R et al. Effectiveness, safety, and tolerability of powdered Nigella sativa (kalonji) seed in capsules on serum lipid levels, blood sugar, blood pressure, and body weight in adults: results of a randomized, double-blind controlled trial. J Altern Complement Med 2009; 15: 639-644
• 22 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. Faseb J 2008; 22: 659-661
• 23 Korashy HM, Maayah ZH, Abd-Allah AR et al. Camel milk triggers apoptotic signaling pathways in human hepatoma HepG2 and breast cancer MCF7 cell lines through transcriptional mechanism. J Biomed Biotechnol 2012; 2012: 593195
• 24 Iba MM, Soyka LF, Schulman MP. Characteristics of the liver microsomal drug-metabolizing enzyme system of newborn rats. Mol Pharmacol 1977; 13: 1092-1104
• 25 Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
• 26 Korashy HM, El-Kadi AO. Differential effects of mercury, lead and copper on the constitutive and inducible expression of aryl hydrocarbon receptor (AHR)-regulated genes in cultured hepatoma Hepa 1c1c7 cells. Toxicology 2004; 201: 153-172
• 27 Al-Jenoobi FI. Effects of some commonly used Saudi folk herbal medications on the metabolic activity of CYP2C9 in human liver microsomes. Saudi Pharm J 2010; 18: 167-171
• 28 Miners JO, Smith KJ, Robson RA et al. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations. Biochem Pharmacol 1988; 37: 1137-1144
• 29 Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci 2006; 78: 2105-2115
• 30 Miners JO, Birkett DJ. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998; 45: 525-538
• 31 Chan K, Lo AC, Yeung JH et al. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 1995; 47: 402-406
• 32 Al-Jenoobi FI, Al-Suwayeh SA, Muzaffar I et al. Effects of Nigella sativa and Lepidium sativum on cyclosporine pharmacokinetics. Biomed Res Int 2013; 2013: 953520
• 33 Al-Mohizea AM, Ahad A, El-Maghraby GM et al. Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs. Eur J Drug Metab Pharmacokinet 2014;
• 34 Al-Jenoobi FI, Alam MA, Alkharfy KM et al. Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine. Eur J Drug Metab Pharmacokinet 2013;
• 35 Alkharfy KM, Al-Jenoobi FI, Alam MA et al. Lepidium sativum but not Nigella sativa affects carbamazepine disposition in an animal model. Drug Metab Lett 2013; 7: 47-51
• 36 Alkharfy KM, Al-Jenoobi FI, Al-Mohizea AM et al. Effects of Lepidium sativum, Nigella sativa and Trigonella foenum-graceum on phenytoin pharmacokinetics in beagle dogs. Phytother Res 2013; 27: 1800-1804
• 37 Wang HJ, Pao LH, Hsiong CH et al. Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship. Aaps J 2014; 16: 258-268
• 38 Hodek P, Trefil P, Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002; 139: 1-21
• 39 Jones BC, Hawksworth G, Horne VA et al. Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase). Drug Metab Dispos 1996; 24: 260-266
• 40 Iranshahy M, Iranshahi M. Traditional uses, phytochemistry and pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin) – a review. J Ethnopharmacol 2011; 134: 1-10
• 41 Miyazawa M, Shindo M, Shimada T. Metabolism of (+)- and (−)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Drug Metab Dispos 2002; 30: 602-607
• 42 Si D, Wang Y, Zhou YH et al. Mechanism of CYP2C9 inhibition by flavones and flavonols. Drug Metab Dispos 2009; 37: 629-634